Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 1
1952 8
1953 37
1954 27
1955 34
1956 72
1957 75
1958 98
1959 98
1960 97
1961 94
1962 148
1963 208
1964 265
1965 179
1966 206
1967 238
1968 221
1969 272
1970 271
1971 275
1972 365
1973 411
1974 472
1975 504
1976 522
1977 593
1978 683
1979 685
1980 744
1981 711
1982 721
1983 755
1984 784
1985 793
1986 828
1987 785
1988 749
1989 789
1990 782
1991 756
1992 681
1993 674
1994 662
1995 587
1996 623
1997 636
1998 558
1999 520
2000 515
2001 534
2002 506
2003 548
2004 496
2005 621
2006 542
2007 566
2008 568
2009 592
2010 594
2011 592
2012 594
2013 649
2014 612
2015 632
2016 665
2017 657
2018 656
2019 663
2020 748
2021 741
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

33,133 results
Results by year
Filters applied: . Clear all
Page 1
Combined therapy with levothyroxine and liothyronine for hypothyroidism.
Fischman A, Domínguez JM. Fischman A, et al. Medwave. 2018 Dec 14;18(8):e7376. doi: 10.5867/medwave.2018.08.7375. Medwave. 2018. PMID: 30550536 English, Spanish.
It has been suggested that the a combined treatment with liothyronine and levothyroxine would provide a greater benefit. METHODS: We searched in Epistemonikos, the largest database of systematic reviews in health, which is maintained by screening multiple information sourc …
It has been suggested that the a combined treatment with liothyronine and levothyroxine would provide a greater benefit. METHODS: We …
Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document.
Jonklaas J, Bianco AC, Cappola AR, Celi FS, Fliers E, Heuer H, McAninch EA, Moeller LC, Nygaard B, Sawka AM, Watt T, Dayan CM. Jonklaas J, et al. Thyroid. 2021 Feb;31(2):156-182. doi: 10.1089/thy.2020.0720. Thyroid. 2021. PMID: 33276704 Review.
Background: Fourteen clinical trials have not shown a consistent benefit of combination therapy with levothyroxine (LT4) and liothyronine (LT3). Despite the publication of these trials, combination therapy is widely used and patients reporting benefit continue to generate …
Background: Fourteen clinical trials have not shown a consistent benefit of combination therapy with levothyroxine (LT4) and liothyronine
Successful treatment of myxedema coma with a combination of levothyroxine and liothyronine.
Ueda K, Kiyota A, Tsuchida M, Okazaki M, Ozaki N. Ueda K, et al. Endocr J. 2019 May 28;66(5):469-474. doi: 10.1507/endocrj.EJ18-0469. Epub 2019 Mar 8. Endocr J. 2019. PMID: 30853666 Free article.
Immediately, he received intensive supportive care and a combination therapy of 200 mug levothyroxine and 50 mug liothyronine until the fifth hospital day. Subsequently, monotherapy with levothyroxine was continued at a dose of 150 mug daily. ...This case demonstrated the …
Immediately, he received intensive supportive care and a combination therapy of 200 mug levothyroxine and 50 mug liothyronine until t …
Management of primary hypothyroidism: statement by the British Thyroid Association Executive Committee.
Okosieme O, Gilbert J, Abraham P, Boelaert K, Dayan C, Gurnell M, Leese G, McCabe C, Perros P, Smith V, Williams G, Vanderpump M. Okosieme O, et al. Clin Endocrinol (Oxf). 2016 Jun;84(6):799-808. doi: 10.1111/cen.12824. Epub 2015 Jun 25. Clin Endocrinol (Oxf). 2016. PMID: 26010808 Free article. Review.
These guidelines have been based on extensive reviews of the medical literature and include sections on the role of combination therapy with L-T4 and liothyronine (L-T3) in individuals who are persistently dissatisfied with L-T4 therapy. ...
These guidelines have been based on extensive reviews of the medical literature and include sections on the role of combination therapy with …
Treatment of hypothyroidism with levothyroxine plus liothyronine: a randomized, double-blind, crossover study.
Kaminski J, Miasaki FY, Paz-Filho G, Graf H, Carvalho GA. Kaminski J, et al. Arch Endocrinol Metab. 2016 Nov-Dec;60(6):562-572. doi: 10.1590/2359-3997000000192. Epub 2016 Aug 25. Arch Endocrinol Metab. 2016. PMID: 27982198 Clinical Trial.
OBJECTIVE: To compare the effects of a unique fixed combination levothyroxine/liothyronine (LT4/LT3) therapy in patients with primary hypothyroidism. ...
OBJECTIVE: To compare the effects of a unique fixed combination levothyroxine/liothyronine (LT4/LT3) therapy in patients with primary …
Triiodothyronine.
Hoffenberg R. Hoffenberg R. Clin Endocrinol (Oxf). 1973 Jan;2(1):75-87. doi: 10.1111/j.1365-2265.1973.tb03487.x. Clin Endocrinol (Oxf). 1973. PMID: 4588947 Review. No abstract available.
Repositioning liothyronine for cancer immunotherapy by blocking the interaction of immune checkpoint TIGIT/PVR.
Zhou X, Du J, Wang H, Chen C, Jiao L, Cheng X, Zhou X, Chen S, Gou S, Zhao W, Zhai W, Chen J, Gao Y. Zhou X, et al. Cell Commun Signal. 2020 Sep 7;18(1):142. doi: 10.1186/s12964-020-00638-2. Cell Commun Signal. 2020. PMID: 32894141 Free PMC article.
Liothyronine could enhance the function of CD4(+) and CD8(+) T cells in PBMCs. ...The immune cell depletion model showed that the anti-tumor effects of liothyronine depends on CD4(+) T cells, CD8(+) T cells and NK cells. ...
Liothyronine could enhance the function of CD4(+) and CD8(+) T cells in PBMCs. ...The immune cell depletion model showed that the ant
REVIEW: Treatment of hypothyroidism with combinations of levothyroxine plus liothyronine.
Escobar-Morreale HF, Botella-Carretero JI, Escobar del Rey F, Morreale de Escobar G. Escobar-Morreale HF, et al. J Clin Endocrinol Metab. 2005 Aug;90(8):4946-54. doi: 10.1210/jc.2005-0184. Epub 2005 May 31. J Clin Endocrinol Metab. 2005. PMID: 15928247 Free article. Review.
However, in some of these studies the patients preferred levothyroxine plus liothyronine combinations, for reasons not explained by changes in the psychological and psychometric tests employed. Yet patients' preference should be balanced against the possibility of adverse …
However, in some of these studies the patients preferred levothyroxine plus liothyronine combinations, for reasons not explained by c …
Triiodothyronine.
[No authors listed] [No authors listed] Lancet. 1971 May 1;1(7705):898-9. Lancet. 1971. PMID: 4102035 No abstract available.
Trends in costs and prescribing for liothyronine and levothyroxine in England and wales 2011-2020.
Stedman M, Taylor P, Premawardhana L, Okosieme O, Dayan C, Heald AH. Stedman M, et al. Clin Endocrinol (Oxf). 2021 Jun;94(6):980-989. doi: 10.1111/cen.14414. Epub 2021 Mar 21. Clin Endocrinol (Oxf). 2021. PMID: 33411974
Nevertheless, 0.5% of levothyroxine-treated patients continue to receive liothyronine. All Clinical Commission Groups (CCGs) in England continue to have at least one liothyronine prescribing practice and 48.5% of English general practices prescribed liothyronine
Nevertheless, 0.5% of levothyroxine-treated patients continue to receive liothyronine. All Clinical Commission Groups (CCGs) in Engla …
33,133 results
You have reached the last available page of results. Please see the User Guide for more information.